Felodipine Tablet, Film Coated
Product Images NDC 72162-1743

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 72162-1743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (1 Formula)

Image Description (1 Formula)
Chemical structure of Felodipine showing its molecular backbone with two chlorine atoms, a methoxy group, and an ethyl ester functional group.*
FDA Label Image

Label (Lbl721621743)

Label (Lbl721621743)
Felodipine Extended-Release Tablets, USP 5 mg film-coated tablets label showing the NDC number 72162-1743-5. The label indicates the product contains 5 mg Felodipine per extended-release tablet and includes storage instructions to keep at 20° to 25°C and protect from light. The package contains 500 tablets. The labeler is Bryant Ranch Prepack, and the manufacturer is Yung Shin Pharmaceutical Ind. Co., Ltd.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A data table titled "Mean Reductions in Blood Pressure (mmHg)" presenting results from two studies over 8 and 4 weeks. It shows dose groups, sample sizes (N), systolic/diastolic mean peak response, mean trough response, and trough/peak ratios expressed as percentages for Felodipine doses ranging from 2.5 mg to 20 mg.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
Data table showing the percent of patients experiencing adverse events during controlled trials of Felodipine extended-release tablets at doses 2.5 mg, 5 mg, and 10 mg compared to placebo. The table lists adverse events categorized by body system, including peripheral edema, headache, nausea, and others, presenting incidence rates and discontinuation percentages in parentheses.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.